Stock listing
NASDAQ:PPCO Penwest Pharmaceuticals Co Stock
Follow Penwest Pharmaceuticals Co into a list and get an email when it puts out news.
Last close · NASDAQ:PPCO
$4.99 USD
Close on Nov 4, 2010 · No longer trades
- Lowest – highest close
- $0.37 – $24.89 USDSince Jan 4, 1999 · lowest Nov 21, 2008 · highest Jul 28, 2003
Delisted NASDAQ:PPCO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:PPCO
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Penwest Pharmaceuticals Co on 6ix
- Decks
- 8 decks · latest Jun 14, 2010
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Proxy Contest (June 2010) | Proxy contest | 43 slides | Jun 14, 2010 |
| Proxy Contest (June 2010) | Proxy contest | 25 slides | Jun 4, 2010 |
| Proxy Contest (June 2010) | Proxy contest | 43 slides | Jun 3, 2010 |
| Proxy Contest (June 2009) | Proxy contest | 34 slides | Jun 5, 2009 |
| Proxy Contest (May 2009) | Proxy contest | 29 slides | May 27, 2009 |
| Proxy Contest (May 2009) | Proxy contest | 32 slides | May 22, 2009 |
| Proxy Contest (May 2009) | Proxy contest | 32 slides | May 20, 2009 |
| Investor Presentation (December 2008) | Investor deck | 17 slides | Dec 4, 2008 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Anne VanLent Other companies: Trevi Therapeutics, Inc. (Director · Since at least May 7, 2019); Novelion Therapeutics Inc (Director · Nov 29, 2016 – Dec 22, 2016 · Past); Traws Pharma, Inc. (Director · Jul 24, 2013 – Jun 15, 2015 · Past); Vaxart, Inc. (Director · May 1, 2013 – Jun 12, 2019 · Past); Aegerion Pharmaceuticals Inc (Director · Apr 26, 2013 – Nov 29, 2016 · Past); Ocera Therapeutics Inc (Director · Apr 1, 2011 – Dec 11, 2017 · Past); Integra LifeSciences Holdings Corporation (Director · May 17, 2006 – May 17, 2012 · Past); Barrier Therapeutics Inc (Exec VP & CFO · Mar 31, 2006 – Mar 14, 2008 · Past) | Director · Jan 3, 2006 – Nov 4, 2010 · Past |
| Jennifer Good Other companies: Rhythm Pharmaceuticals, Inc. (Director · Since at least Jun 19, 2019); Trevi Therapeutics, Inc. (President and Chief Executive Officer · Since at least May 7, 2019); Juniper Pharmaceuticals Inc (Director · Sep 7, 2017 – Aug 14, 2018 · Past) | President & CEO · Apr 28, 2010 – Nov 4, 2010 · Past |
| Saiid Zarrabian Other companies: TuHURA Biosciences, Inc. (Head of Strategic Partnerships, Director · Jul 7, 2017 – Dec 6, 2021 · Past); La Jolla Pharmaceutical Co (Director · Jan 19, 2012 – May 14, 2015 · Past) | Director · Jun 30, 2010 – Sep 20, 2010 · Past |
| Benjamin L Palleiko Other companies: KalVista Pharmaceuticals, Inc. (CHIEF EXECUTIVE OFFICER, Director · Since at least Nov 21, 2016) | SVP, Corporate Dev. & CFO · Jun 19, 2006 – Jun 18, 2008 · Past |
| Christophe Bianchi Other companies: Millennium Pharmaceuticals Inc (Executive Vice President · Feb 1, 2006 – May 14, 2008 · Past) | Director · Jun 21, 2007 – Jan 4, 2010 · Past |
| Paul E Freiman Other companies: Neurobiological Technologies Inc (President and CEO, Director · Sep 19, 2006 – May 30, 2008 · Past) | Director · Jan 3, 2006 – Jan 4, 2010 · Past |
| Peter F Drake Other companies: Direct Markets Holdings Corp (Director · Oct 15, 2007 – May 6, 2011 · Past) | Director · Jan 3, 2006 – Sep 20, 2010 · Past |
| Amale Hawi | SVP, Pharmaceutical Dev. · Apr 25, 2007 – Nov 4, 2010 · Past |
| Anand Baichwal | SVP Licensing & BD · Feb 3, 2006 – Nov 4, 2010 · Past |
| John G Lemkey | Director · Jun 30, 2010 – Jun 30, 2010 · Past |
All 12 people
| Person | Seat |
|---|---|
| Paul F Hayes | VP, Strategic Marketing · Apr 11, 2007 – Mar 5, 2009 · Past |
| Robert Hennessey | Director · Jan 3, 2006 – Jan 2, 2009 · Past |
Log in to ask 6ix AI your own questions about Penwest Pharmaceuticals Co.